4 completed, 1 terminated, 1 unknown. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Soft Tissue Neoplasms: new trials by email Literature Review of Soft Tissue Neoplasms trials Research Report on Soft Tissue Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors TAEST16001 - Liver Cancer Stage IV, Gastric Cancer Stage IV | Phase 1 | Completed | Zhujiang Hospital | 6 | 2017-04-14 | 2020-01-22 |
| Study of MEK162 for Children With Low-Grade Gliomas MEK162 - Low-Grade Gliomas, Malignant Neoplasms, Brain | Phase 1 / Phase 2 | Completed | Children's Hospital Los Angeles | 105 | 2016-05-04 | 2025-10-07 |
| Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease Bevacizumab, Cetuximab, Laboratory Biomarker Analysis - Advanced Malignant Neoplasm, Castleman Disease | Phase 1 | Terminated | M.D. Anderson Cancer Center | 116 | 2012-10-16 | 2026-11-05 |
| Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics 18F-Al-NOTA-PRGD2 PET/CT - Tumors, Carcinoma, Bronchogenic | Phase 1 | Unknown | Wuxi No. 4 People's Hospital | 200 | 2012-01-01 | 2017-03-10 |
| Vaccine Therapy in Treating Patients With Metastatic Cancer interleukin-2, MAGE-12 peptide vaccine, Montanide ISA-51 - Lung Cancer, Adult Soft Tissue Sarcoma | Phase 1 | Completed | National Cancer Institute (NCI) | 2000-07-01 | 2024-03-04 | |
| Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors doxorubicin HCl liposome - Childhood Soft Tissue Sarcoma, Childhood Liver Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 1999-07-01 | 2024-03-04 |
Breast Neoplasms (4) · Neoplasms (4) · Bone Neoplasms (2) · Brain Neoplasms (2) · Endocrine Gland Neoplasms (2) · Gastrointestinal Neoplasms (2) · Genetic Diseases, Inborn (2) · Histiocytoma, Malignant Fibrous (2) · Muscle Neoplasms (2) · Neuroectodermal Tumors, Primitive, Peripheral (2) · Osteosarcoma (2) · Recurrence (2) · Sarcoma (2) · Thyroid Neoplasms (2)
Neoplasms by Site (6) · Breast Diseases (4) · Neoplasms by Histologic Type (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Endocrine System Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Gastrointestinal Diseases (3) · Male Urogenital Diseases (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms, Germ Cell and Embryonal (3)
Bevacizumab (1) · Cetuximab (1) · Disulfides (1) · Immunoglobulin G (1) · Interleukin-2 (1) · Sirolimus (1) · Valproic Acid (1) · binimetinib (1) · montanide ISA 51 (1) · temsirolimus (1)
National Cancer Institute (NCI) (2) · Children's Hospital Los Angeles (1) · M.D. Anderson Cancer Center (1) · Wuxi No. 4 People's Hospital (1) · Zhujiang Hospital (1)
United States (4) · China (2)
Elizabeth Lowe (1) · Francesco M. Marincola (1) · Jian Zhang (1) · Nathan Robison, MD (1) · Sarina A Piha-Paul (1) · Weixing Wan, Professor (1)
PMID 16818691, PMID 18077538, PMID 26933802, PMID 37311055, PMID 38967722, PMID 41389341